NCT04207086 2025-12-16
Neo PeLe
Melanoma Institute Australia
Phase 2 Active not recruiting
Clinical Trials
4 trialsNCT04955743 2025-11-24
Pembrolizumab and Lenvatinib in Patients With Brain Metastases From Melanoma or Renal Cell Carcinoma
Yale University
Phase 2 Terminated
NCT05282901 2025-11-24
PLUME
Institut Curie
Phase 2 Active not recruiting
NCT05308901 2025-07-25
Lenvatinib Plus Pembrolizumab In Patients With Immune Checkpoint Inhibitor Naïve Metastatic Uveal Melanoma
Providence Health & Services
Phase 2 Active not recruiting